Machine Learning

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

CodeSignal's new AI interviews candidates by phone in 20+ languages, promising a revolution in efficiency. But can it overcome the hurdles of bias and empathy?

A new contract for specialized titanium powder signals a major shift in manufacturing, securing critical supply chains for a booming $1.4B market.

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

A Canadian youth sports leader's entry into India reveals a blueprint for AI-driven physical literacy and a new paradigm for children's healthcare.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.

As AI fuels a new arms race in cyberspace, an innovative training model emerges to arm human defenders. Is this the future of cybersecurity education?

An award-winning telecom platform reveals how AI-driven, unified journeys can transform customer experience. What can healthcare learn from this model?

A global service provider has cracked the code on talent retention. What can the defense and aerospace sectors learn from its people-first strategy?

A French cancer institute is the first in Europe to deploy a new radiotherapy system that promises not just better accuracy, but a more humane patient journey.

Behind the rise of regional streaming giant Chaupal lies a massive tech overhaul. Discover how a B2B partnership enabled a seamless 10M user migration.

Husqvarna unveils a massive cost-cutting plan alongside ambitious growth and green targets. Can this strategic pivot secure its future market leadership?

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

A 1.01 Tbps cyberattack was just a skirmish in a wider war. See how advanced AI and massive defenses are the new front line against digital extortion.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.